Why Apple Services Segment Could Be the Next Big Thing
Apple reported better-than-expected fiscal first-quarter financial results after markets closed on Tuesday.
All Work
Chris Lange
How Under Armour Stacks Up Against Nike and Lululemon
Under Armour has been one of the biggest cult stocks over the past few years with shares making gains like clockwork. But this earnings report throws all that into question, not to mention there…
Why Analysts Are Chasing Momenta Pharmaceuticals Even Higher
Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) saw its shares make a huge gain on Tuesday after the firm reported a key legal decision in its favor. Essentially, the U.S. District Court for the District of…
Are Analysts Becoming Too Negative on Fitbit After Earnings?
Initially it was the preliminary results that pushed Fitbit shares down, but now the fallout is coming from analysts dropping their price targets.
Top 5 Earnings Coming Out on Wednesday
Though earnings season is slowing down, there are still a few companies left in the mix that could put the wind back in the market’s sails.
Will Visa Beat MasterCard and Amex Earnings?
Mastercard came out with its fourth-quarter earnings on Tuesday morning, and they did not live up to expectations, but Visa is set to report later this week and could trump Mastercard’s earnings.
How Eli Lilly Earnings Won Big on New Drug Sales
Eli Lilly released a mixed fourth-quarter earnings report and offered full-year guidance before the markets opened on Tuesday.
Are Pfizer’s Acquisitions Holding Back Its Bottom Line?
When Pfizer reported its fourth-quarter financial results before the markets opened on Tuesday, earnings fell short of consensus estimates.
Wedbush’s 6 Best Idea Stocks for 50% Upside (or Much More)
Wedbush has issued a report with some of its best ideas for 2016. These top six ideas from this list have implied upside of at least 50%.
Is This the Beginning of EyeGate’s Rally?
Eyegate Pharmaceuticals, Inc. (NASDAQ: EYEG) saw its shares rise handily on Monday following positive top-line results from the company’s first-in-human pilot trial. Specifically, the trial is for the EyeGate Ocular Bandage Gel (OBG) for…
Why the Rigel Pharmaceuticals Update Could Signal Further Growth
Rigel Pharmaceuticals shares saw a solid gain to kick off the week after the company gave an update on one of its clinical programs.
Top 7 Earnings Reports to Look For Tuesday
24/7 Wall St. has put together a preview of some of the major companies reporting on Tuesday, including Apple and two other Dow stocks.
Why This Collaboration Is So Important for Calithera
Shares of Calithera Biosciences saw a solid gain early on Monday after the company reported a global collaboration and licensing agreement with Incyte.
Fitbit Shows How Broken Business Models Feel
Fitbit saw its shares slide on Monday after the company announced preliminary fourth-quarter results and a business update that did not live up to expectations due to a softer-than-expected holiday season.
2 Charged in Huge ‘Hamilton’ Ticket Resale Ponzi Scheme
The SEC has announced fraud charges against two New York City men accused of running a Ponzi scheme with money raised from investors to fund businesses purportedly created to purchase and resell tickets to…
Why the Pulmatrix Pullback Makes Sense
Pulmatrix saw its shares take a sharp downturn on Monday morning after the company announced that it had entered into a definitive agreement with several investors for a direct offering valued up to roughly…
What to Expect From Dow Stocks Reporting This Week
Five of the Dow stocks are reporting next week, and this has the potential to sustain the run that the index has made since the Trump rally began and push it even further beyond…
What to Expect From Apple Earnings
Apple is scheduled to report its fiscal first-quarter financial results on Tuesday after the markets closed. A fair number of analysts already have weighed in on Apple.
Why Analysts Favor Microsoft Over Alphabet After Earnings
Microsoft has been quickly rising over the past year and is closing in on Alphabet in terms of market capitalization. Analysts seem to think Microsoft can eclipse its rival.
Why Analysts Favor Intel Over Qualcomm
Intel and Qualcomm each just reported their most recent earnings, and there was a clear winner and clear loser this past week.